Cairo – Mubasher: Rimco EGT Investment increased its 2.10% stake in Macro Group Pharmaceuticals - Macro Capital to 5.43%, according to a bourse filing.
Rimco EGT Investment bought 19.21 million shares in the EGX-listed company for EGP 61.48 million, at an average price of EGP 3.20 per share.
Meanwhile, Commercial International Brokerage Company (CIBC) was the broker for the transaction that was executed on 28 March 2023.
Last year, Macro Group witnessed a hike in consolidated net profit after tax to EGP 173.87 million, versus EGP 147.96 million in 2021, including minority interest.
Revenues climbed to EGP 729.61 million in 2022 from EGP 594.25 million a year earlier, while the basic and diluted earnings per share (EPS) increased to EGP 0.30 from EGP 0.26.
The total assets amounted to EGP 849.63 million as of 31 December 2022, an annual jump from EGP 577.09 million.
